Rhinomed Ltd

ASX:RNO ISIN:AU000000RNO1

Rhinomed Limited ASX:RNO

Rhinomed Limited (ASX:RNO) is a Melbourne based, medical technology firm with a focus on nasal, respiratory and breathing management technologies. The company is seeking to monetise applications of its technology portfolio in the Sport, Sleep, Wellbeing and Drug Delivery markets. For more information, go to www.rhinomed.global

TwitterFollow the Turbine on Twitter at @theturbinecom
Follow Mute Snoring on Twitter at @mutesnoring

       

News

Rhinomed Ltd (ASX:RNO) Completes AUD $3.6 Million Capital Raising

🕔11/29/2017 9:44:28 AM 751

Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF) a leading sleep and nasal respiratory technology company has successfully undertaken an AUD$3.6 million placement to institutional and sophisticated private investors at $0.15 per share.

Read Full Article

Rhinomed Ltd (ASX:RNO) Investor Presentation October 2017

🕔10/5/2017 10:24:59 AM 1403

Rhinomed Ltd (ASX:RNO) (OTCMKTS:RHNMF) provides the Company's latest Investor Presentation.

Read Full Article

Rhinomed Ltd (ASX:RNO) Preliminary Final Report

🕔8/28/2017 6:45:01 PM 846

The Directors of Rhinomed Limited ASX:RNO) provide the following Report in relation to the Group for the year ended 30 June 2017.

Read Full Article

Rhinomed Limited (ASX:RNO) Froome Wins 4th Tour De France Using Turbine

🕔7/25/2017 2:49:05 PM 1616

A yellow nose ring matches the yellow jersey. Chris Froome, having taken his 4th Tour de France title continues to support yellow - in the form of an innovative sports breathing device called Turbine(TM).

Read Full Article

Rhinomed Ltd (ASX:RNO) Major Expansion of Mute USA Retail Footprint

🕔7/17/2017 9:55:16 AM 1793

Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF), is pleased to announce that it has been advised that its sleep and breathing technology Mute, has been added to the annual 'large set' planogram produced by the Hamacher Resource Group, Inc.

Read Full Article

Rhinomed Ltd (ASX:RNO) May 2017 Investor Update - Delivering End to End Sleep Category Solutions

🕔5/16/2017 9:59:50 AM 2160

Rhinomed Ltd (ASX:RNO) (OTCMKTS:RHNMF) are pleased to provide the Company's latest Investor Update for May 2017.

Read Full Article

Rhinomed Ltd (ASX:RNO) Amcal and Guardian Core Range Mute Australia Wide

🕔5/8/2017 10:11:03 AM 2837

Respiratory technology company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to announce that it has been advised by Sigma Healthcare (ASX:SIG) that Mute sleep technology will form part of the 2017 core range for the Amcal and Guardian pharmacy brands.

Read Full Article

Rhinomed Ltd (ASX:RNO) Announce GNC USA (NYSE:GNC) to Sell Mute

🕔4/6/2017 10:03:47 AM 2544

Respiratory technology company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to announce further expansion of its North American retail distribution footprint having received confirmation that its Mute sleep technology will go on sale in 811 GNC Holdings Inc. health, wellness and performance stores.

Read Full Article

Rhinomed Ltd (ASX:RNO) Adds US Based Cornerstone Investors and Initiates Capital Management Program

🕔3/15/2017 4:53:14 PM 2598

Rhinomed (ASX:RNO) advises it has undertaken a AUD$2.19 million private placement to two US based sophisticated investor groups as part of its 15% placement capacity. In addition, the company has flagged its intention to hold a General Meeting to approve a capital management initiative that will seek to consolidate the company's capital and provide a sale of less than marketable share parcels facility.

Read Full Article

Rhinomed Ltd (ASX:RNO) Mute Global Distribution Milestone Update

🕔3/8/2017 12:18:23 PM 2523

Rhinomed (ASX:RNO) is pleased to provide an update on the expansion of its global distribution program. The company can report that Rhinomed has been added as a vendor by two major US based pharmacy wholesalers and the successful expansion of the listing of its Mute Sleep technology by Symbion in Australia.

Read Full Article
###

20,563 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 112) (Last 30 Days: 505) (Since Published: 20579) 

Markets ASX:RNO

Company Data

    Headquarters
  • 97 Green St
    Cremorne
    Vic 3121
    Australia
  • Telephone
  • +61-3-8416-0900 
  • Fax
  • +61-3-8080-0796 
  • Principal Sector
  • Consumers 
  • Principal Industry
  • Medical Products 
  • Homepage
  • www.rhinomed.com.au
  • E:
  • mjohnson@rhinomed.com.au

Company Reports

Presentations

Quarterly Report

Social Media